Credit: motortion/AdobeStock
News
Greenberg Traurig, Goodwin Act on Japanese Pharma's $2.4B American Acquisition
Greenberg Traurig advised ONO Pharmaceuticals while Goodwin Procter acted for Deciphera.
May 02, 2024 at 02:12 PM
1 minute read
Mergers and Acquisitions
Greenberg Traurig and Goodwin Procter are advising on the $2.4 billion sale of American cancer drugmaker Deciphera to Japanese company ONO Pharmaceutical.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 2The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 3First Lawsuit Filed Alleging Contraceptive Depo-Provera Caused Brain Tumor
- 4The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 5Elder Litigators Confront Tough Questions in Last Act of Careers
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
